Credit Suisse Initiates Coverage of Agilent with Outperform Rating | GenomeWeb

NEW YORK (GenomeWeb News) – Investment bank Credit Suisse today initiated coverage of Agilent Technologies with an Outperform rating and a $48 price target.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: role for RNA splicing in genetic variation, and more.

An advocacy group sues the US Food and Drug Administration over redactions of information about advisory committee members, Stat News reports.

Mexico is trying to lure young genomics researchers back home with their own labs, Science reports.

A molecular autopsy has aided a woman's search for why sudden cardiac death has stalked her family, the Wall Street Journal reports.